Targeting Inflammation and Alloimmunity in Heart Transplant Recipients With Tocilizumab (RTB-004)
Phase of Trial: Phase II
Latest Information Update: 09 Feb 2019
At a glance
- Drugs Tocilizumab (Primary) ; Methylprednisolone; Mycophenolate sodium; Prednisolone; Tacrolimus; Tacrolimus; Tacrolimus
- Indications Heart transplant rejection
- Focus Therapeutic Use
- 03 Dec 2018 Status changed from not yet recruiting to recruiting.
- 07 Nov 2018 Planned initiation date changed from 1 Oct 2018 to 1 Nov 2018.
- 12 Sep 2018 Planned initiation date changed from 1 Sep 2018 to 1 Oct 2018.